肠道硫酸化对预防结肠炎和结肠癌至关重要
本研究探讨了PAPSS2介导的硫酸化在结肠炎和结肠癌变中的作用。分析人类结肠癌标本和小鼠模型发现,PAPSS2表达在结肠癌中降低且与患者生存期差相关;肠道特异性Papss2敲除小鼠对结肠炎和结肠癌更敏感,机制涉及黏膜屏障损伤、胆汁酸积累和硫酸化胆汁酸缺乏。
要点
- PAPSS2在人和小鼠结肠癌中表达降低,低表达与患者生存期差相关。
- 肠道特异性Papss2敲除小鼠对结肠炎和结肠癌更敏感。
- 机制涉及肠黏膜屏障受损、胆汁酸积累及硫酸化胆汁酸形成缺陷。
核心结论
- PAPSS2介导的肠道硫酸化在结肠炎和结肠癌变中起重要保护作用。
- 肠道硫酸化可能作为诊断标志物,PAPSS2可能成为炎症性肠病和结肠癌的治疗靶点。
研究设计与样本
- 分析人类结肠癌组织芯片、基因表达数据和患者临床特征。
- 构建肠道特异性Papss2敲除小鼠(Papss2ΔIE),进行DSS诱导结肠炎及AOM/DSS或AOM诱导结肠癌变实验。
主要发现
- PAPSS2在人和小鼠结肠癌中表达降低,低表达与结肠癌患者生存期差相关。
- Papss2ΔIE小鼠对结肠炎和结肠癌敏感性增高,表现为肠黏膜屏障损伤、肠道通透性增加、细菌浸润和肿瘤微环境恶化。
- Papss2ΔIE小鼠肠道硫黏蛋白含量减少。
- 代谢组学显示Papss2ΔIE小鼠结肠中胆汁酸积累,包括FXR拮抗剂牛磺-β-鼠胆酸,且胆汁酸硫酸盐形成缺陷。
临床怎么用
- PAPSS2表达水平可能作为结肠癌患者的预后或诊断标志物。
- 靶向PAPSS2介导的硫酸化通路可能为炎症性肠病和结肠癌提供治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Sulfation is a conjugation reaction essential for numerous biochemical and cellular functions in mammals. The 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase 2 (PAPSS2) is the key enzyme to generate PAPS, which is the universal sulfonate donor for all sulfation reactions. The goal of this study was to determine whether and how PAPSS2 plays a role in colitis and colonic carcinogenesis. METHODS: Tissue arrays of human colon cancer specimens, gene expression data, and clinical features of cancer patients were analyzed. Intestinal-specific Papss2 knockout mice (Papss2ΔIE) were created and subjected to dextran sodium sulfate-induced colitis and colonic carcinogenesis induced by a combined treatment of azoxymethane and dextran sodium sulfate or azoxymethane alone. RESULTS: The expression of PAPSS2 is decreased in the colon cancers of mice and humans. The lower expression of PAPSS2 in colon cancer patients is correlated with worse survival. Papss2ΔIE mice showed heightened sensitivity to colitis and colon cancer by damaging the intestinal mucosal barrier, increasing intestinal permeability and bacteria infiltration, and worsening the intestinal tumor microenvironment. Mechanistically, the Papss2ΔIE mice exhibited reduced intestinal sulfomucin content. Metabolomic analyses revealed the accumulation of bile acids, including the Farnesoid X receptor antagonist bile acid tauro-β-muricholic acid, and deficiency in the formation of bile acid sulfates in the colon of Papss2ΔIE mice. CONCLUSIONS: We have uncovered an important role of PAPSS2-mediated sulfation in colitis and colonic carcinogenesis. Intestinal sulfation may represent a potential diagnostic marker and PAPSS2 may serve as a potential therapeutic target for inflammatory bowel disease and colon cancer.
引用
- Xu P, Xi Y, Zhu J, et al. Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis. Gastroenterology. 2021. PMID: 33819483. doi:10.1053/j.gastro.2021.03.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。